Statement of Changes in Beneficial Ownership (4)
2013年2月6日 - 6:45AM
Edgar (US Regulatory)
|
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Williams Michael J PhD
|
2. Issuer Name
and
Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE
[
IDXX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Vice President
|
|
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/1/2013
|
|
(Street)
WESTBROOK, ME 04092
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
|
Common Stock
|
2/1/2013
|
|
M
|
|
7668
|
A
|
$53.3100
|
17696
(1)
|
D
|
|
|
Common Stock
|
2/1/2013
|
|
M
|
|
15764
|
A
|
$56.9500
|
33460
|
D
|
|
|
Common Stock
|
2/1/2013
|
|
S
|
|
23432
|
D
|
$94.6815
|
10028
|
D
|
|
|
Common Stock
|
2/1/2013
|
|
S
|
|
862
|
D
|
$94.9644
|
9166
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
|
Non-Qualified Stock Option (right to buy)
|
$53.3100
|
2/1/2013
|
|
M
|
|
7668
|
|
(2)
|
2/13/2017
|
Common Stock
|
7668
|
$0
|
9627
|
D
|
|
|
Non-Qualified Stock Option (right to buy)
|
$56.9500
|
2/1/2013
|
|
M
|
|
15764
|
|
(3)
|
2/13/2015
|
Common Stock
|
15764
|
$0
|
2186
|
D
|
|
|
Explanation of Responses:
|
|
(
1)
|
Includes 63 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2012.
|
|
(
2)
|
Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013 and 02/14/2014 and the remaining 1,959 shares on 02/14/2015.
|
|
(
3)
|
Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011 and the remaining 2,186 shares on 02/14/2013.
|
Reporting Owners
|
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Williams Michael J PhD
ONE IDEXX DRIVE
WESTBROOK, ME 04092
|
|
|
Executive Vice President
|
|
Signatures
|
|
Conan R. Deady, Attorney-in-Fact for Michael J. Williams, PhD
|
|
2/5/2013
|
|
**
Signature of Reporting Person
|
Date
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 6 2024 まで 7 2024
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 7 2023 まで 7 2024
